Konstantinov Konstantin's Form 4 filing
Codiak BioSciences, Inc.CDAK · filed Mar 30, 2023
- Accession no.
- 0000950170-23-011029
- Filed
- Mar 30, 2023, 5:13 PM ET
- Trade date
- Mar 28, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $1.87K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Konstantinov KonstantinCIK 0001774649 | Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 28, 2023 | Common Stock | SSaleDisposed | −7,432 | $0.2001 | −$1,487.14 | 1,932 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −1,932 | $0.20 | −$386.4 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.